F E D E R I C A M A Z Z U C A
A Z I E N D A O S P E D A L I E R A S A N T ’ A N D R E A U N I V E R S I T À D I R O M A « S A P I E N Z A » F E D E R I C A . M A Z Z U C A @ U N I R O M A 1 . I T
Gastrointestinal – non colorectal
GASTRIC CANCER 1. FLOT4
2. JACOB
3. ATTRACTION 02 4. KEYNOTE 059
Biliary tract Cancer 1. Bilcap
2. Prodige 12- Accord 18 Hepatocellular Carcinoma 1. Reflect study
Gastric Cancer
Gastric cancer
OS in pp Population (predefined analysis)
OS – multivariate analysis
OS – prognostic impact of Histology
OS – subgroup analysis
Gastric cancer
JACOB
JACOB
Gastric cancer
ATTRACTION-02
ATTRACTION-02
Gastric cancer
KEYNOTE-059
KEYNOTE-059
KEYNOTE-059
KEYNOTE-059
BiliaryTract Cancer
Biliary Tract Cancer
PRODIGE 12-ACCORD 18
Aim: RFS, maintaining health-related quality of life (Hr-QoL)
Biliary Tract Cancer
Biliary Tract Cancer
Hepatocellular carcinoma
Hepatocellular carcinoma
REFLECT STUDY
REFLECT STUDY
The best of the year meets the first post Esmo:
CONCLUSIONS
Gastric Cancer
•negative results for adjuvant GEMOX
•but… YES for Xeloda
Biliary Tract Cancer
•Lenvatinib: it is really better than sorafenib?
Hepatocellular Carcinoma